Skip to main content
FinSpry Logo
FinSpry
ARVN logo
ARVN
(NASDAQ)
Arvinas, Inc.
$7.67-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arvinas (ARVN) Stock Price & Financial Analysis

Arvinas Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.52 - $8.02
52-Week High$14.51
52-Week Low$6.06
Open$7.85
Volume957.39K
Average Volume (3M)848.88K
Market Cap490.88M
Shares Outstanding64.00M
Price to Sales (P/S)5.49
Price to Book (P/B)1.27
EV/EBITDA-1.75
Revenue (TTM)89.40M
Net Income (TTM)-221.30M
Free Cash Flow (TTM)-256.90M
EPS (TTM)$-3.22
Profit Margin-247.54%
Operating Margin-279.31%
Return on Equity (ROE)-57.21%
Debt to Equity0.02
50-Day MA$9.31
200-Day MA$10.66
52-Week Change2.68%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arvinas

What is the current stock price for ARVN?

As of the latest trading session, ARVN stock trades at $7.67. The 52-week range is $6.06–$14.51, with a day range of $7.52–$8.02.

What is the P/E ratio for ARVN?

The P/E ratio (Price-to-Earnings) for ARVN is shown in the Key Statistics section. This valuation metric helps compare Arvinas, Inc. to industry peers.

Does ARVN pay dividends?

Arvinas does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARVN?

Based on 8 analysts, the consensus for ARVN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ARVN?

Arvinas's market capitalization is $490.9M, classifying it as a small-cap company. Arvinas operates in the Healthcare sector within the Biotechnology industry.